Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

Billions of dollars worth of U.S. biomanufacturing plant development has been announced, and site selection will likely be ...

In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), talks ...

Odin Industries is proud to announce the acquisition of Florida based A Doc on Wheels, a respected provider of mobile medical services. Effective June 3, 2025, the company will be rebranded as Shield ...

Here are some highlights from the first half of the year: ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Collegium Pharmaceutical (NASDAQ:COLL) and its peers. The ...

Eli Lilly (NYSE:LLY) recently announced promising Phase 1 data for its folate receptor alpha antibody-drug conjugate, ...

Elon Musk has been feuding with President Trump over a bill the president is championing that, among other things, cuts incentives for electric vehicles and solar energy that benefit Musk’s ...